TL;DR
This paper presents a rare case of a neonate with complex congenital heart defects, including bilateral coronary artery fistulas and multiple collateral arteries, and identifies a potential genetic cause. The findings highlight the importance of whole-exome sequencing in unraveling the genetic underpinnings of such intricate conditions and suggest a novel role for the DRC1 gene in human congenital heart disease.
What Problem Does This Paper Address?
Congenital heart defects (CHDs) are a diverse group of conditions affecting the heart's structure, with coronary artery fistulas being a relatively uncommon subset. While many CHDs are thought to have a genetic component, the specific genetic mutations responsible for complex presentations, especially those involving multiple anomalies like coronary fistulas and collateral arteries, are often not well understood. This paper addresses the challenge of identifying the genetic basis for a particularly complex and rare presentation of CHD in a neonate, aiming to contribute to our understanding of the genetic etiology of these conditions.
Methods
The study employed a multi-faceted approach combining clinical diagnosis, interventional procedures, and advanced genetic analysis.
- Clinical Diagnosis and Intervention: The patient underwent detailed clinical evaluation, including echocardiography and cardiac catheterization, to diagnose the specific cardiac malformations. Surgical interventions were performed to repair the identified defects.
- Whole-Exome Sequencing (WES): WES was performed on the patient and her parents to identify genetic variations. This technique sequences the protein-coding regions of the genome, which are most likely to harbor disease-causing mutations.
- Bioinformatic Analysis: Raw WES data was processed using standard bioinformatics pipelines (GATK, BWA, SAMtools) for variant calling and filtering. This involved removing low-quality reads, aligning sequences to a reference genome, and identifying single nucleotide variants (SNVs) and insertions/deletions (indels).
- Variant Prioritization: A rigorous filtering process was applied to identify candidate causative variants. This included filtering for rare variants (minor allele frequency < 1%), non-synonymous variants, and variants predicted to be deleterious by multiple computational algorithms (SIFT, Poly-Phen-2, Mutation Taster, CADD). Candidate genes were then prioritized based on their known association with CHD and inheritance patterns (recessive, compound heterozygous, de novo).
Datasets
- Patient and Parental DNA: Genomic DNA was extracted from peripheral blood samples of the neonate and her parents for WES.
- Public Control Databases: For variant filtering, the study utilized public control databases including 1,000 Genomes Project, ESP5600, and gnomAD (gnomAD_ALL and gnomAD_EAS) to identify rare variants.
- Reference Genome: The human reference genome (GRCh37/hg19) was used for sequence alignment.
Key Insights and Ideas
- Complex CHD Presentation: The case highlights an exceptionally complex congenital heart defect involving bilateral coronary artery fistulas, multiple aortic collateral arteries, a patent ductus arteriosus, and an atrial septal defect, presenting a significant clinical challenge.
- Potential Role of DRC1 Gene: The study identifies compound heterozygous variants in the DRC1 gene (c.T470G and c.A1622G) as the most likely genetic cause of the patient's CHD. This is a novel finding, as DRC1 has not been previously strongly linked to human congenital heart disease, though it has been implicated in mouse models of CHD.
- Conservation of DRC1 Variants: The identified variants affect amino acid residues (Leucine at position 157 and Aspartic acid at position 541) that are highly conserved across various species, suggesting their functional importance.
- Domain-Specific Impact: The variants are located in or near domains of the DRC1 protein (SYD-28 and NYD-SP28 assoc) that are implicated in ciliary function, which is known to play a role in cardiovascular development. This provides a potential mechanistic link between DRC1 mutations and CHD.
Key Results
- Clinical Recovery: The patient underwent successful surgical repair and showed uneventful recovery, growing well at a 3-year follow-up.
- Genetic Findings: Whole-exome sequencing identified 17 variants within 11 genes in the patient compared to her parents. Among these, compound heterozygous variants in the DRC1 gene were identified as the most probable cause of the CHD.
- Variant Details: The specific variants identified were c.T470G (p.L157R) inherited from the father and c.A1622G (p.D541G) inherited from the mother, both within the DRC1 gene. These variants were predicted to be deleterious by multiple computational tools.
Limitations and Future Work
- WES Limitations: The authors acknowledge that WES may miss intronic variants that could play a significant role in CHD pathogenesis.
- Confirmation of Causality: While strong evidence points to DRC1 variants, further confirmation through Sanger sequencing and animal model experiments is suggested to definitively establish the causal link between the identified genetic variants and the unique CHD phenotype.
- Functional Studies: Future research could focus on functional studies to elucidate the precise mechanism by which DRC1 mutations contribute to cardiovascular development and lead to complex CHD presentations.
- Broader Genetic Landscape: Given the complexity of CHD, exploring other potential genetic contributors beyond the identified DRC1 variants would be valuable.
Summary updated